Cargando…
Novel drugs in the management of difficult-to-treat hepatitis C genotypes
BACKGROUND: Hepatitis C virus (HCV) infection is the most common chronic bloodborne infection in the United States, with approximately 3.2 million Americans being chronically infected. Rates of HCV-related end-stage liver disease and its associated morbidity and mortality have yet to peak, so there...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953740/ https://www.ncbi.nlm.nih.gov/pubmed/24696624 http://dx.doi.org/10.2147/HMER.S48545 |